3189 results for «694»

Filter By

3189 results

Featured research - Tricuspid valve (Part 1)

24 Nov 2024 – From PCR London Valves 2024

Explore the latest research on tricuspid valve interventions in this featured session from PCR London Valves 2024. Discover insights on the prognostic impact of heart failure hospitalization in severe tricuspid regurgitation, the influence of moderate mitral regurgitation in tricuspid TEER patients, the association of effective right...

Featured research - Tricuspid valve (Part 1)

Rapid-fire - TAVI in aortic regurgitation

24 Nov 2024 – From PCR London Valves 2024

Prepare to be captivated by a rapid-fire session showcasing selected PCR London Valves 2024 clinical cases on TAVI in aortic regurgitation. Witness the first-in-man deployment of the Abbott Navitor Valve for left ventricular assist device-associated aortic regurgitation, as well as cases involving severe aortic regurgitation in...

Rapid-fire - TAVI in aortic regurgitation

Featured cases - Strategic approaches in mitral regurgitation

24 Nov 2024 – From PCR London Valves 2024

Immerse yourself in this featured session showcasing strategic approaches in the management of mitral regurgitation. Explore a range of complex cases, including percutaneous annuloplasty with a novel device in functional mitral regurgitation, the management of mitral annulus cavity and regurgitation post-healed endocarditis, simultaneous management of two...

Featured cases - Strategic approaches in mitral regurgitation

TAVI innovations: latest breakthroughs from PCR London Valves 2024

24 Nov 2024 – From PCR London Valves 2024

Curious about the latest advancements shaping the future of TAVI? Don't miss this video which deliver insights from the PCR London Valves 2024 Late-Breaking Trials, diving into key topics that matter most in clinical practice.

Explore 5-year outcomes of AVR in low-risk patients stratified by annulus size,...

TAVI innovations: latest breakthroughs from PCR London Valves 2024

Featured research - Aortic valve (Part 4)

24 Nov 2024 – From PCR London Valves 2024

Featured research - Aortic valve (Part 4)

Featured cases - Challenging tricuspid interventions (Part 2)

24 Nov 2024 – From PCR London Valves 2024

Dive into this session showcasing a diverse array of challenging tricuspid interventions from the PCR London Valves 2024 Clinical Cases submissions. Discover complex cases involving TTVR in a transplanted heart, recurrent tricuspid regurgitation after T-TEER, and an extremely difficult tricuspid valve-in-valve implantation. Gain insights on navigating...

Featured cases - Challenging tricuspid interventions (Part 2)

The PASCAL IID Registry: A prospective registry for transcatheter edge-to-edge repair in prohibitive risk patients with degenerative mitral regurgitation and complex mitral valve anatomy

17 Sep 2022

Alex Sticchi provides his take on the PASCAL IID Registry and an initial comparison with the CLASP IID. The trial was presented by Jörg Hausleiter during TCT Congress 2022.

Alessandro Sticchi

Author

Alessandro Sticchi
The PASCAL IID Registry: A Prospective Registry for Transcatheter Edge-to-Edge Repair in Prohibitive Risk Patients With Degenerative MR and Complex Mitral Valve Anatomy

Frequency and safety of bioprosthetic valve fracture in patients undergoing valve in valve TAVR for failed surgical valves using the SAPIEN 3/Ultra Valves: Insights from real-world data

19 Sep 2022

Michele Pighi provides his take on this trial which aimed to compare the safety and efficacy of VIV-TAVI with or without bioprosthetic valve fracture. It was presented by Santiago Garcia during the TCT Congress 2022.

M. Pighi

Author

Michele Pighi
Bioprosthetic valve fracture in ViV-TAVR

ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial

07 Nov 2022

Mirvat Alasnag provides her take on the ECMO-CS trial, which was presented during AHA 2022 in Chicago, and simultaneously published in Circulation. 

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial
Didn’t find what you were looking for?